{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T18:49:28Z","timestamp":1769626168971,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tice.2025.103220","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:25:10Z","timestamp":1762597510000},"page":"103220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tranilast inhibits cell proliferation, migration and invasion of human hypertrophic scar fibroblasts by NOP2-mediated m5C methylation on COL1A1"],"prefix":"10.1016","volume":"99","author":[{"given":"Sihang","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beixue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tice.2025.103220_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0041-1731461","article-title":"Current advances in hypertrophic scar and keloid management","volume":"35","author":"Barone","year":"2021","journal-title":"Semin Plast. Surg."},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40659-017-0127-6","article-title":"MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1","volume":"50","author":"Bi","year":"2017","journal-title":"Biol. Res."},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/genes10020102","article-title":"Eukaryotic 5-methylcytosine (m(5)C) RNA methyltransferases: mechanisms, cellular functions, and links to disease","volume":"10","author":"Bohnsack","year":"2019","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.tice.2025.103220_bib4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.21873\/invivo.12886","article-title":"Nanomicelle-generating microneedles loaded with tranilast for treatment of hypertrophic scars in a rabbit model","volume":"36","author":"Chien","year":"2022","journal-title":"In vivo (Athens)"},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","article-title":"RNA modifications: importance in immune cell biology and related diseases","volume":"7","author":"Cui","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"1-2","key":"10.1016\/j.tice.2025.103220_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol. Med. (Cambridge, Mass)"},{"issue":"8","key":"10.1016\/j.tice.2025.103220_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1242\/jcs.181040","article-title":"Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1","volume":"129","author":"Hong","year":"2016","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1566523222666220901112314","article-title":"miRNA-1260b promotes breast cancer cell migration and invasion by downregulating CCDC134","volume":"23","author":"Huang","year":"2023","journal-title":"Curr. Gene Ther."},{"issue":"3","key":"10.1016\/j.tice.2025.103220_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030711","article-title":"Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.tice.2025.103220_bib10","article-title":"Laser therapy for treating hypertrophic and keloid scars","volume":"9","author":"Leszczynski","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.tice.2025.103220_bib11","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.burns.2018.01.008","article-title":"The recovery of post-burn hypertrophic scar in a monitored pressure therapy intervention programme and the timing of intervention","volume":"44","author":"Li","year":"2018","journal-title":"Burns"},{"issue":"12","key":"10.1016\/j.tice.2025.103220_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2174\/0109298665245603231106050224","article-title":"Unleashing breast cancer progression: miR-455-5p's targeting of SOCS3 drives proliferation, migration, and invasion","volume":"30","author":"Li","year":"2023","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","article-title":"5-methylcytosine RNA methyltransferases and their potential roles in cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tice.2025.103220_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111529","article-title":"Significant roles of RNA 5-methylcytosine methylation in cancer","volume":"126","author":"Lou","year":"2025","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.tice.2025.103220_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.64.3.5","article-title":"The RNA m5C methylase NSUN2 modulates corneal epithelial wound healing","volume":"64","author":"Luo","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.tice.2025.103220_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.apsb.2021.03.016","article-title":"Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatment","volume":"11","author":"Ning","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"21","key":"10.1016\/j.tice.2025.103220_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.drudis.2008.08.009","article-title":"New therapeutics for the prevention and reduction of scarring","volume":"13","author":"Occleston","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tice.2025.103220_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111844","article-title":"Anti-cancer effects of Tranilast: an update","volume":"141","author":"Osman","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.tice.2025.103220_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2230.2001.00891.x","article-title":"Extracellular matrix and keratinocyte migration","volume":"26","author":"O'Toole","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1874467215666220308122716","article-title":"MiR-129-2-3p inhibits esophageal carcinoma cell proliferation, migration, and invasion via targeting DNMT3B","volume":"16","author":"Peng","year":"2023","journal-title":"Curr. Mol. Pharm."},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/02844319709085482","article-title":"Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast","volume":"31","author":"Shigeki","year":"1997","journal-title":"Scand. J. Plast. Reconstr. Surg. Hand Surg."},{"key":"10.1016\/j.tice.2025.103220_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkz003","article-title":"Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence","volume":"8","author":"Shirakami","year":"2020","journal-title":"Burns Trauma"},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PRS.0000000000005275","article-title":"Topical oxandrolone reduces ear hypertrophic scar formation in rabbits","volume":"143","author":"Sobec","year":"2019","journal-title":"Plast. Reconstr. Surg. (1963)"},{"issue":"39","key":"10.1016\/j.tice.2025.103220_bib24","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","article-title":"NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization","volume":"40","author":"Su","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-5198(19)32429-1","article-title":"The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J. Pharmacol."},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-5198(19)32428-X","article-title":"Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J. Pharmacol."},{"issue":"2","key":"10.1016\/j.tice.2025.103220_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","article-title":"RNA modifications in cancer","volume":"129","author":"Tang","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.tice.2025.103220_bib28","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.7150\/ijbs.97503","article-title":"NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression","volume":"20","author":"Tian","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tice.2025.103220_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.788801","article-title":"NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma","volume":"12","author":"Tong","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.tice.2025.103220_bib30","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.jid.5700786","article-title":"Keratinocyte\u2013Fibroblast Interactions in Wound Healing","volume":"127","author":"Werner","year":"2007","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.tice.2025.103220_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1380697","article-title":"RNA m5C methylation modification: a potential therapeutic target for SARS-CoV-2-associated myocarditis","volume":"15","author":"Xiong","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.tice.2025.103220_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70016","article-title":"ALKBH5-mediated m6A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis","volume":"14","author":"Xu","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"3","key":"10.1016\/j.tice.2025.103220_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/wound.2013.0485","article-title":"Extracellular matrix reorganization during wound healing and its impact on abnormal scarring","volume":"4","author":"Xue","year":"2015","journal-title":"Adv. Wound Care (New Rochelle)"},{"issue":"4","key":"10.1016\/j.tice.2025.103220_bib34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","article-title":"Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts","volume":"116","author":"Yamada","year":"1994","journal-title":"J. Biochem."},{"issue":"7","key":"10.1016\/j.tice.2025.103220_bib35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-024-06899-w","article-title":"NOP2 facilitates EZH2-mediated epithelial-mesenchymal transition by enhancing EZH2 mRNA stability via m5C methylation in lung cancer progression","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tice.2025.103220_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-023-01814-x","article-title":"LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling","volume":"22","author":"Yang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2025.103220_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1028410","article-title":"Mechanotransduction in skin wound healing and scar formation: potential therapeutic targets for controlling hypertrophic scarring","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.tice.2025.103220_bib38","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1021\/acsnano.1c11016","article-title":"Down-regulating scar formation by microneedles directly via a mechanical communication pathway","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.tice.2025.103220_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110287","article-title":"Current potential therapeutic strategies targeting the TGF-beta\/Smad signaling pathway to attenuate keloid and hypertrophic scar formation","volume":"129","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tice.2025.103220_bib40","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.2147\/IJN.S433510","article-title":"Exosome derived from mesenchymal stem cells alleviates hypertrophic scar by inhibiting the fibroblasts via TNFSF-13\/HSPG2 signaling pathway","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomed."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625005026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625005026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:24:21Z","timestamp":1769577861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625005026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"alternative-id":["S0040816625005026"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.103220","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranilast inhibits cell proliferation, migration and invasion of human hypertrophic scar fibroblasts by NOP2-mediated m5C methylation on COL1A1","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.103220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103220"}}